Zacks: Brokerages Expect Trupanion, Inc. (TRUP) Will Post Quarterly Sales of $65.60 Million

Wall Street analysts expect that Trupanion, Inc. (NASDAQ:TRUP) will post sales of $65.60 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Trupanion’s earnings, with the highest sales estimate coming in at $65.90 million and the lowest estimate coming in at $65.30 million. Trupanion posted sales of $51.34 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 27.8%. The company is expected to issue its next earnings report on Tuesday, February 13th.

According to Zacks, analysts expect that Trupanion will report full-year sales of $65.60 million for the current fiscal year, with estimates ranging from $241.40 million to $242.00 million. For the next year, analysts anticipate that the business will post sales of $294.80 million per share, with estimates ranging from $291.10 million to $298.50 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow Trupanion.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, November 2nd. The financial services provider reported $0.01 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.04. Trupanion had a negative return on equity of 7.41% and a negative net margin of 1.05%. The business had revenue of $63.12 million for the quarter, compared to analyst estimates of $61.44 million. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. The company’s revenue was up 30.5% on a year-over-year basis.

A number of equities research analysts have recently weighed in on TRUP shares. BidaskClub lowered Trupanion from a “hold” rating to a “sell” rating in a research note on Thursday, September 7th. CL King began coverage on Trupanion in a research note on Tuesday, November 21st. They set a “neutral” rating on the stock. Zacks Investment Research lowered Trupanion from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $35.00 target price (up previously from $29.00) on shares of Trupanion in a research report on Tuesday, October 31st. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Trupanion currently has a consensus rating of “Buy” and a consensus target price of $28.83.

In related news, CFO Tricia Plouf sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $32.11, for a total value of $32,110.00. Following the sale, the chief financial officer now owns 14,000 shares in the company, valued at $449,540. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Howard E. Rubin sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $25.90, for a total value of $2,590,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 118,539 shares of company stock worth $3,146,008. 31.24% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Tokio Marine Asset Management Co. Ltd. acquired a new position in Trupanion in the third quarter valued at approximately $325,000. Vanguard Group Inc. lifted its holdings in Trupanion by 3.7% in the first quarter. Vanguard Group Inc. now owns 650,459 shares of the financial services provider’s stock valued at $9,249,000 after acquiring an additional 23,419 shares during the period. Goldman Sachs Group Inc. acquired a new position in Trupanion in the second quarter valued at approximately $993,000. Baillie Gifford & Co. lifted its holdings in Trupanion by 12.3% in the second quarter. Baillie Gifford & Co. now owns 982,373 shares of the financial services provider’s stock valued at $21,985,000 after acquiring an additional 107,373 shares during the period. Finally, Swiss National Bank lifted its holdings in Trupanion by 21.7% in the second quarter. Swiss National Bank now owns 31,910 shares of the financial services provider’s stock valued at $714,000 after acquiring an additional 5,700 shares during the period. Hedge funds and other institutional investors own 63.25% of the company’s stock.

Shares of Trupanion (NASDAQ TRUP) traded down $0.17 during mid-day trading on Wednesday, hitting $32.16. The stock had a trading volume of 135,900 shares, compared to its average volume of 163,511. Trupanion has a 1-year low of $13.71 and a 1-year high of $33.00. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 1.87.

COPYRIGHT VIOLATION NOTICE: “Zacks: Brokerages Expect Trupanion, Inc. (TRUP) Will Post Quarterly Sales of $65.60 Million” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/20/zacks-brokerages-expect-trupanion-inc-trup-will-post-quarterly-sales-of-65-60-million.html.

Trupanion Company Profile

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply